Preliminary exploration of amide proton transfer weighted imaging in differentiation between benign and malignant bone tumors

被引:0
|
作者
Li, Ying [1 ]
Lin, Liangjie [2 ]
Zhang, Yong [1 ]
Ren, Cuiping [1 ]
Zhang, Wenhua [1 ]
Cheng, Jingliang [1 ]
机构
[1] Zhengzhou Univ, Dept Magnet Resonance Imaging, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Philips Healthcare, Clin & Tech Support, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
bone tumor; amide proton transfer weighted imaging; diffusion weighted imaging; differential diagnosis; magnetic resonance imaging; SKELETAL LESIONS; MRI;
D O I
10.3389/fonc.2024.1402628
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To explore the value of 3D amide proton transfer weighted imaging (APTWI) in the differential diagnosis between benign and malignant bone tumors, and to compare the diagnostic performance of APTWI with traditional diffusion-weighted imaging (DWI). Materials and methods Patients with bone tumors located in the pelvis or lower limbs confirmed by puncture or surgical pathology were collected from January 2021 to July 2023 in the First Affiliated Hospital of Zhengzhou University. All patients underwent APTWI and DWI examinations. The magnetization transfer ratio with asymmetric analysis at the frequency offset of 3.5 ppm [MTRasym(3.5 ppm)] derived by APTWI and the apparent diffusion coefficient (ADC) derived by DWI for the tumors were measured. The Kolmogorou-Smirnou and Levene normality test was used to confirm the normal distribution of imaging parameters; and the independent sample t test was used to compare the differences in MTRasym(3.5 ppm) and ADC between benign and malignant bone tumors. In addition, the receiver operating characteristic (ROC) curve was used to evaluate the diagnostic performance of different imaging parameters in differentiation between benign and malignant bone tumors. P<0.05 means statistically significant. Results Among 85 bone tumor patients, 33 were benign and 52 were malignant. The MTRasym(3.5 ppm) values of malignant bone tumors were significantly higher than those of benign tumors, while the ADC values were significantly lower in benign tumors. ROC analysis shows that MTRasym(3.5 ppm) and ADC values perform well in the differential diagnosis of benign and malignant bone tumors, with the area under the ROC curve (AUC) of 0.798 and 0.780, respectively. Combination of MTRasym(3.5 ppm) and ADC values can further improve the diagnostic performance with the AUC of 0.849 (sensitivity = 84.9% and specificity = 73.1%). Conclusion MTRasym(3.5 ppm) of malignant bone tumors was significantly higher than that of benign bone tumors, reflecting the abnormal increase of protein synthesis in malignant tumors. APTWI combined with DWI can achieve a high diagnostic efficacy in differentiation between benign and malignant bone tumors.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Can diffusion-weighted imaging distinguish between benign and malignant pediatric liver tumors?
    Caro-Dominguez, Pablo
    Gupta, Abha A.
    Chavhan, Govind B.
    PEDIATRIC RADIOLOGY, 2018, 48 (01) : 85 - 93
  • [42] Amide proton transfer-weighted imaging and stretch-exponential model DWI based 18F-FDG PET/MRI for differentiation of benign and malignant solitary pulmonary lesions
    Nan Meng
    Chen Song
    Jing Sun
    Xue Liu
    Lei Shen
    Yihang Zhou
    Bo Dai
    Xuan Yu
    Yaping Wu
    Jianmin Yuan
    Yang Yang
    Zhe Wang
    Meiyun Wang
    Cancer Imaging, 24
  • [43] Can diffusion-weighted imaging distinguish between benign and malignant pediatric liver tumors?
    Pablo Caro-Domínguez
    Abha A. Gupta
    Govind B. Chavhan
    Pediatric Radiology, 2018, 48 : 85 - 93
  • [44] Amide proton transfer imaging for differentiation of tuberculomas from high-grade gliomas: Preliminary experience
    Kulanthaivelu, Karthik
    Jabeen, Shumyla
    Saini, Jitender
    Raju, Sanita
    Nalini, Atchayaram
    Sadashiva, Nishanth
    Hegde, Shashank
    Rolla, Narayana Krishna
    Saha, Indrajit
    Netravathi, M.
    Vengalil, Seena
    Swaroop, Saikrishna
    Rao, Shilpa
    NEURORADIOLOGY JOURNAL, 2021, 34 (05): : 440 - 448
  • [45] Evaluation of the molecular origin of amide proton transfer-weighted imaging
    Sun, Casey
    Zhao, Yu
    Zu, Zhongliang
    MAGNETIC RESONANCE IN MEDICINE, 2023, 2 (716-734) : 716 - 734
  • [46] Differentiation between glioblastoma and solitary brain metastases using perfusion and amide proton transfer weighted MRI
    Knutsson, Malte
    Salomonsson, Tim
    Durmo, Faris
    Johansson, Emelie Ryd
    Seidemo, Anina
    Laett, Jimmy
    Rydelius, Anna
    Kinhult, Sara
    Englund, Elisabet
    Bengzon, Johan
    van Zijl, Peter C. M.
    Knutsson, Linda
    Sundgren, Pia C.
    FRONTIERS IN NEUROSCIENCE, 2025, 19
  • [47] A new approach for imaging brain tumors: Amide proton transfer (APT) imaging
    Blakeley, Jaishri O.
    Van Zijl, Peter
    Pomper, Martin G.
    Jones, Craig
    Laterra, John
    Zhou, Jinyuan
    NEUROLOGY, 2007, 68 (12) : A288 - A288
  • [48] Feasibility of Amide Proton Transfer-weighted Imaging at 3T for Renal Masses: A Preliminary Study
    Xu, Yun
    Wan, Qingxuan
    Ren, Xihui
    Jiang, Yutao
    Yao, Jing
    Wu, Peng
    Shen, Aijun
    Wang, Peijun
    Current Medical Imaging, 2024, 20
  • [49] Differentiation of Malignant Spinal Tumors From Benign Lesions with Single Shot Echoplanar Diffusion Weighted MR Imaging
    Razek, Abdel A.
    Omran, E.
    Soliman, N.
    Soliman, N.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (05)
  • [50] The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors
    Doganay, Selim
    Altinok, Tayfun
    Alkan, Alpay
    Kahraman, Bayram
    Karakas, Hakki Muammer
    EUROPEAN JOURNAL OF RADIOLOGY, 2011, 79 (02) : E33 - E37